The Latin American medical tourism market reached $14.61 billion in 2026 and is projected to hit $58.38 billion by 2034, growing at 18.9% annually. Colombia's medical tourism segment alone is projected to reach $6.3 billion by 2032. This isn't a niche — it's a structural shift in how Americans access healthcare.
Medical tourism in Latin America has crossed the threshold from “emerging trend” to “established industry.” The numbers tell the story.
Market Size & Growth
The Latin American medical tourism market was valued at $12.29 billion in 2025 and reached an estimated $14.61 billion in 2026, growing at a compound annual growth rate of 18.9%. Projections indicate the market will reach $58.38 billion by 2034. To contextualize: this industry is growing faster than most tech sectors.
Country Market Share
Mexico leads on volume with approximately 1.2 million American medical tourists annually, driven primarily by dental and bariatric surgery. Colombia's medical tourism market is projected to reach $6.3 billion by 2032, with the fastest growth rate in the region driven by cosmetic surgery, fertility, and increasingly complex procedures (cardiac, orthopedic). Brazil's medical tourism market is projected to grow from $3.7 billion in 2025 to $16.3 billion by 2034. Costa Rica generates over $437 million annually from health tourism.
Growth Drivers
Three forces are compounding. First, U.S. healthcare costs continue to rise: out-of-pocket spending averages $1,650–$1,700 per person annually, and 27 million Americans remain uninsured. Second, Latin American healthcare infrastructure is improving: JCI accreditation is expanding, surgeon training pathways are deepening, and digital infrastructure (telemedicine consultations, electronic medical records) is bridging the pre-operative gap. Third, awareness is normalizing: as more patients return from successful procedures abroad, word-of-mouth is converting the skeptical.
Emerging Trends
The market is evolving beyond cosmetic surgery and dental work into higher-complexity procedures: cardiac surgery, orthopedics, oncology, and fertility. Telemedicine pre-consultations are becoming standard, allowing patients to evaluate surgeons virtually before committing to travel. GLP-1 medications (Ozempic, Wegovy) may reduce bariatric surgery volume but are simultaneously increasing demand for post-weight-loss body contouring. And employer-sponsored medical tourism programs are emerging as a cost-containment strategy for self-insured companies.
For comprehensive Colombia-specific guidance across all medical specialties, see ColombiaMedical.co.
Ready to Explore Your Options?
Get a free, no-obligation quote from accredited clinics across Latin America.
Get My Free Quote